Medical and dialytic management of hyperkalemia in hemodialysis patients

被引：3
作者：
Allon, M
机构：
[1] UNIV ALABAMA,CTR NEPHROL RES & TRAINING,BIRMINGHAM,AL 35294
[2] VET ADM MED CTR,BIRMINGHAM,AL
来源：
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS | 1996年 / 19卷 / 12期
关键词：
D O I：
10.1177/039139889601901203
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
引用
收藏
页码：697 / 699
页数：3
相关论文
共 17 条
  • [11] GUTTIEREZ R, 1991, MINER ELECTROLYTE ME, V17, P297
  • [12] LENS XM, 1989, NEPHROL DIAL TRANSPL, V4, P228
  • [13] LIOU HH, 1994, AM J KIDNEY DIS, V26, P266
  • [14] POTASSIUM-LOWERING EFFECT OF ALBUTEROL FOR HYPERKALEMIA IN RENAL-FAILURE
    MONTOLIU, J
    LENS, XM
    REVERT, L
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (04) : 713 - 717
  • [15] VARIABILITY IN POTASSIUM REMOVAL BY HEMODIALYSIS
    SHERMAN, RA
    HWANG, ER
    BERNHOLC, AS
    EISINGER, RP
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 1986, 6 (04) : 284 - 288
  • [16] HEMODIALYSATE COMPOSITION AND INTRADIALYTIC METABOLIC, ACID-BASE AND POTASSIUM CHANGES
    WARD, RA
    WATHEN, RL
    WILLIAMS, TE
    HARDING, GB
    [J]. KIDNEY INTERNATIONAL, 1987, 32 (01) : 129 - 135
  • [17] WILLIAMS AJ, 1984, P EUR DIAL T ASS, V21, P209
12